Published in J Pathol on August 01, 2007
Integration site preference of xenotropic murine leukemia virus-related virus, a new human retrovirus associated with prostate cancer. J Virol (2008) 2.83
Interferon-inducible protein, P56, inhibits HPV DNA replication by binding to the viral protein E1. EMBO J (2008) 1.66
BANF1 is downregulated by IRF1-regulated microRNA-203 in cervical cancer. PLoS One (2015) 1.44
Non-random integration of the HPV genome in cervical cancer. PLoS One (2012) 1.43
Functional variants of human papillomavirus type 16 demonstrate host genome integration and transcriptional alterations corresponding to their unique cancer epidemiology. BMC Genomics (2016) 1.38
Characterization of HPV and host genome interactions in primary head and neck cancers. Proc Natl Acad Sci U S A (2014) 1.37
Mechanism of genomic instability in cells infected with the high-risk human papillomaviruses. PLoS Pathog (2009) 1.34
Epithelial cell responses to infection with human papillomavirus. Clin Microbiol Rev (2012) 1.33
Multiplex Identification of Human Papillomavirus 16 DNA Integration Sites in Cervical Carcinomas. PLoS One (2013) 1.19
The mRNA decay factor tristetraprolin (TTP) induces senescence in human papillomavirus-transformed cervical cancer cells by targeting E6-AP ubiquitin ligase. Aging (Albany NY) (2009) 1.14
In vitro progression of human papillomavirus 16 episome-associated cervical neoplasia displays fundamental similarities to integrant-associated carcinogenesis. Cancer Res (2010) 1.10
HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress. Future Virol (2011) 1.10
The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections. Microbiol Mol Biol Rev (2009) 1.09
Human papillomavirus molecular biology and disease association. Rev Med Virol (2015) 1.09
Differential methylation of the HPV 16 upstream regulatory region during epithelial differentiation and neoplastic transformation. PLoS One (2011) 1.04
Bacteria-human somatic cell lateral gene transfer is enriched in cancer samples. PLoS Comput Biol (2013) 1.04
Development of therapeutic HPV vaccines. Lancet Oncol (2009) 1.04
Human papillomavirus and colorectal cancer: evidences and pitfalls of published literature. Int J Colorectal Dis (2010) 1.00
Role of human papillomaviruses in carcinogenesis. Ecancermedicalscience (2015) 1.00
An RNA aptamer provides a novel approach for the induction of apoptosis by targeting the HPV16 E7 oncoprotein. PLoS One (2013) 0.96
Methylation of human papillomavirus 16, 18, 31, and 45 L2 and L1 genes and the cellular DAPK gene: Considerations for use as biomarkers of the progression of cervical neoplasia. Virology (2013) 0.96
Physical state & copy number of high risk human papillomavirus type 16 DNA in progression of cervical cancer. Indian J Med Res (2014) 0.93
Host-cell factors involved in papillomavirus entry. Med Microbiol Immunol (2012) 0.92
Changes in type-specific human papillomavirus load predict progression to cervical cancer. J Cell Mol Med (2012) 0.92
Oncostatin M receptor is a novel therapeutic target in cervical squamous cell carcinoma. J Pathol (2014) 0.91
Future directions and treatment strategies for head and neck squamous cell carcinomas. Transl Res (2012) 0.90
Current understanding of the role of the Brd4 protein in the papillomavirus lifecycle. Viruses (2013) 0.89
Genetic polymorphisms and cervical cancer development: ATM G5557A and p53bp1 C1236G. Oncol Rep (2011) 0.86
HPV16 E2 could act as down-regulator in cellular genes implicated in apoptosis, proliferation and cell differentiation. Virol J (2011) 0.85
Productive infection of bovine papillomavirus type 2 in the urothelial cells of naturally occurring urinary bladder tumors in cattle and water buffaloes. PLoS One (2013) 0.85
Perspectives for therapeutic HPV vaccine development. J Biomed Sci (2016) 0.85
APOBEC3 deaminases induce hypermutation in human papillomavirus 16 DNA upon beta interferon stimulation. J Virol (2013) 0.85
Comprehensive mapping of the human papillomavirus (HPV) DNA integration sites in cervical carcinomas by HPV capture technology. Oncotarget (2016) 0.85
Tissue transglutaminase mediates the pro-malignant effects of oncostatin M receptor over-expression in cervical squamous cell carcinoma. J Pathol (2013) 0.83
[HPV-associated carcinomas of the female genital tract. Molecular mechanisms of development]. Pathologe (2011) 0.83
An RNA Aptamer Targets the PDZ-Binding Motif of the HPV16 E6 Oncoprotein. Cancers (Basel) (2014) 0.83
Regulation of the Wnt/β-Catenin Signaling Pathway by Human Papillomavirus E6 and E7 Oncoproteins. Viruses (2015) 0.83
β-HPV 5 and 8 E6 disrupt homology dependent double strand break repair by attenuating BRCA1 and BRCA2 expression and foci formation. PLoS Pathog (2015) 0.82
Lessons from Australia: human papillomavirus is not a major risk factor for esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev (2010) 0.82
Structural insights into a wildtype domain of the oncoprotein E6 and its interaction with a PDZ domain. PLoS One (2013) 0.82
Viral carcinogenesis: factors inducing DNA damage and virus integration. Cancers (Basel) (2014) 0.82
Transcriptionally active regions are the preferred targets for chromosomal HPV integration in cervical carcinogenesis. PLoS One (2015) 0.82
Genetic variation of human papillomavirus type 16 in individual clinical specimens revealed by deep sequencing. PLoS One (2013) 0.81
Virus transcript levels and cell growth rates after naturally occurring HPV16 integration events in basal cervical keratinocytes. J Pathol (2014) 0.80
Extracellular calcium regulates keratinocyte proliferation and HPV 16 E6 RNA expression in vitro. APMIS (2014) 0.80
BIRC2 amplification in squamous cell carcinomas of the uterine cervix. Virchows Arch (2012) 0.80
Viral load, integration and methylation of E2BS3 and 4 in human papilloma virus (HPV) 16-positive vaginal and vulvar carcinomas. PLoS One (2014) 0.80
Historical review of the causes of cancer. World J Clin Oncol (2016) 0.79
Correlation between ebv co-infection and HPV16 genome integrity in Tunisian cervical cancer patients. Braz J Microbiol (2012) 0.79
Current state in the development of candidate therapeutic HPV vaccines. Expert Rev Vaccines (2016) 0.79
Human papillomavirus oncoproteins and apoptosis (Review). Exp Ther Med (2013) 0.79
Cell-type specific transcriptional activities among different papillomavirus long control regions and their regulation by E2. Virology (2009) 0.79
Biology of human papillomavirus infection and immune therapy for HPV-related head and neck cancers. Otolaryngol Clin North Am (2012) 0.78
HPV16 oncogene expression levels during early cervical carcinogenesis are determined by the balance of epigenetic chromatin modifications at the integrated virus genome. Oncogene (2016) 0.78
Lipoprotein lipase is frequently overexpressed or translocated in cervical squamous cell carcinoma and promotes invasiveness through the non-catalytic C terminus. Br J Cancer (2012) 0.78
Identification of episomal human papillomavirus and other DNA viruses in cytological anal samples of HIV-uninfected men who have sex with men. PLoS One (2013) 0.78
Sequence variation of human papillomavirus type 16 and measurement of viral integration by quantitative PCR. J Clin Microbiol (2008) 0.78
New technologies for cervical cancer screening. Best Pract Res Clin Obstet Gynaecol (2011) 0.77
Type-specific human papillomavirus E6/E7 mRNA detection by real-time PCR improves identification of cervical neoplasia. J Clin Microbiol (2011) 0.77
HPV Population Profiling in Healthy Men by Next-Generation Deep Sequencing Coupled with HPV-QUEST. Viruses (2016) 0.77
DNA Damage Reduces the Quality, but Not the Quantity of Human Papillomavirus 16 E1 and E2 DNA Replication. Viruses (2016) 0.77
The human papillomavirus E7 oncoprotein as a regulator of transcription. Virus Res (2016) 0.76
Establishment of immunoassay for detecting HPV16 E6 and E7 RNA. Sci Rep (2015) 0.76
Human Papillomavirus: Current and Future RNAi Therapeutic Strategies for Cervical Cancer. J Clin Med (2015) 0.76
Identification of host transcriptional networks showing concentration-dependent regulation by HPV16 E6 and E7 proteins in basal cervical squamous epithelial cells. Sci Rep (2016) 0.75
APOBEC3A associates with human papillomavirus genome integration in oropharyngeal cancers. Oncogene (2016) 0.75
Mate-Pair Sequencing as a Powerful Clinical Tool for the Characterization of Cancers with a DNA Viral Etiology. Viruses (2015) 0.75
Human Papillomavirus (HPV) virion induced cancer and subfertility, two sides of the same coin. Facts Views Vis Obgyn (2017) 0.75
Multiparameter Evaluation of the Heterogeneity of Circulating Tumor Cells Using Integrated RNA In Situ Hybridization and Immunocytochemical Analysis. Front Oncol (2016) 0.75
Integration of high-risk human papillomavirus into cellular cancer-related genes in head and neck cancer cell lines. Head Neck (2017) 0.75
RNA extraction method is crucial for human papillomavirus E6/E7 oncogenes detection. Virol J (2017) 0.75
Molecular mechanisms of HPV mediated neoplastic progression. Infect Agent Cancer (2016) 0.75
Sequence variation in the E2-binding domain of HPV16 and biological function evaluation in Tunisian cervical cancers. Biomed Res Int (2014) 0.75
Diagnosis of 25 genotypes of human papillomaviruses for their physical statuses in cervical precancerous/cancerous lesions: a comparison of E2/E6E7 ratio-based vs. multiple E1-L1/E6E7 ratio-based detection techniques. J Transl Med (2014) 0.75
Cell mediated immunity against HPV16 E2, E6 and E7 peptides in women with incident CIN and in constantly HPV-negative women followed-up for 10-years. J Transl Med (2015) 0.75
Integration of human papillomavirus type 16 in cervical cancer cells. Open Med (Wars) (2014) 0.75
High Prevalence of Human Papillomavirus in Colorectal Cancer in Hispanics: A Case-Control Study. Gastroenterol Res Pract (2016) 0.75
Chronic oxidative stress increases the integration frequency of foreign DNA and human papillomavirus 16 in human keratinocytes. Am J Cancer Res (2016) 0.75
Viral E6 is overexpressed via high viral load in invasive cervical cancer with episomal HPV16. BMC Cancer (2017) 0.75
Comparative study of HPV16 integration in cervical lesions between ethnicities with high and low rates of infection with high-risk HPV and the correlation between integration rate and cervical neoplasia. Exp Ther Med (2015) 0.75
Divergent viral presentation among human tumors and adjacent normal tissues. Sci Rep (2016) 0.75
Genome-wide profiling of the human papillomavirus DNA integration in cervical intraepithelial neoplasia and normal cervical epithelium by HPV capture technology. Sci Rep (2016) 0.75
The molecular mechanism of human papillomavirus-induced carcinogenesis in head and neck squamous cell carcinoma. Int J Clin Oncol (2016) 0.75
Lateral gene transfer between prokaryotes and eukaryotes. Exp Cell Res (2017) 0.75
Evaluation of microRNA-205 expression as a potential triage marker for patients with low-grade squamous intraepithelial lesions. Oncol Lett (2017) 0.75
DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans. Proc Natl Acad Sci U S A (2001) 2.86
Improved cervical smear assessment using antibodies against proteins that regulate DNA replication. Proc Natl Acad Sci U S A (1998) 2.61
cis Expression of DC-SIGN allows for more efficient entry of human and simian immunodeficiency viruses via CD4 and a coreceptor. J Virol (2001) 2.50
Minichromosome maintenance proteins as biological markers of dysplasia and malignancy. Clin Cancer Res (1999) 2.49
Ability of Proteus mirabilis to invade human urothelial cells is coupled to motility and swarming differentiation. Infect Immun (1992) 2.10
Polycystin: in vitro synthesis, in vivo tissue expression, and subcellular localization identifies a large membrane-associated protein. Proc Natl Acad Sci U S A (1997) 1.75
Global microRNA profiles in cervical squamous cell carcinoma depend on Drosha expression levels. J Pathol (2007) 1.74
Placental expression of DC-SIGN may mediate intrauterine vertical transmission of HIV. J Pathol (2001) 1.58
Characterization of events during the late stages of HPV16 infection in vivo using high-affinity synthetic Fabs to E4. Virology (1997) 1.56
The role of swarm cell differentiation and multicellular migration in the uropathogenicity of Proteus mirabilis. J Infect Dis (1994) 1.53
HPV: from infection to cancer. Biochem Soc Trans (2007) 1.47
Cellular characteristics of nipple aspiration fluid during the menstrual cycle in healthy premenopausal women. Cytopathology (2001) 1.46
Mid-dermal elastolysis. Br J Dermatol (1994) 1.44
Prebiotic carbohydrates modify the mucosa associated microflora of the human large bowel. Gut (2004) 1.41
Cellular and subcellular distribution of polycystin-2, the protein product of the PKD2 gene. J Am Soc Nephrol (2000) 1.41
Natural history of prostate cancer. Lancet (1993) 1.37
Altered muscle insulin sensitivity in the male offspring of protein-malnourished rats. Am J Physiol (1996) 1.31
Testicular development in the complete androgen insensitivity syndrome. J Pathol (2006) 1.29
Immunoassay for urothelial cancers that detects DNA replication protein Mcm5 in urine. Lancet (1999) 1.24
Aberrant expression of minichromosome maintenance protein-2 and Ki67 in laryngeal squamous epithelial lesions. Br J Cancer (2003) 1.22
A novel immunohistochemical method for estimating cell cycle phase distribution in ovarian serous neoplasms: implications for the histopathological assessment of paraffin-embedded specimens. Br J Cancer (2004) 1.19
Analysis of pilocytic astrocytoma by comparative genomic hybridization. Br J Cancer (2000) 1.16
Expression and distribution of transforming growth factor-beta isoforms and their signaling receptors in growing human bone. Bone (1998) 1.14
DICER1 hotspot mutations in non-epithelial gonadal tumours. Br J Cancer (2013) 1.13
A novel and consistent amplicon at 13q31 associated with alveolar rhabdomyosarcoma. Genes Chromosomes Cancer (2000) 1.11
A palatal haemangioma in a child. J Laryngol Otol (1998) 1.10
The E1E4 protein of human papillomavirus type 16 associates with a putative RNA helicase through sequences in its C terminus. J Virol (2000) 1.08
Immunolocalisation of vascular endothelial growth factor (VEGF) in human neonatal growth plate cartilage. J Anat (1999) 1.07
Gain and overexpression of the oncostatin M receptor occur frequently in cervical squamous cell carcinoma and are associated with adverse clinical outcome. J Pathol (2007) 1.03
Antral motility measurements by magnetic resonance imaging. Neurogastroenterol Motil (2001) 1.03
Early recurrence of benign meningioma correlates with expression of mini-chromosome maintenance-2 protein. Br J Neurosurg (2002) 1.01
Tie2 ligands angiopoietin-1 and angiopoietin-2 are coexpressed with vascular endothelial cell growth factor in growing human bone. Bone (2001) 1.01
Characterising the local immune responses in cervical intraepithelial neoplasia: a cross-sectional and longitudinal analysis. BJOG (2008) 1.01
Nuclear entry and nucleolar localization of the Newcastle disease virus (NDV) matrix protein occur early in infection and do not require other NDV proteins. J Virol (1992) 1.00
Improved detection of hepatocyte proliferation using antibody to the pre-replication complex: an association with hepatic fibrosis and viral replication in chronic hepatitis C virus infection. J Viral Hepat (2003) 0.99
Epitope-mapped monoclonal antibodies against the HPV16E1--E4 protein. Virology (1992) 0.98
Human atherosclerotic plaques express DC-SIGN, a novel protein found on dendritic cells and macrophages. J Pathol (2002) 0.98
Prognostic value of c-erbB-2 and epidermal growth factor receptor in stage A1 (T1a) prostatic adenocarcinoma. Br J Urol (1994) 0.97
NS6180, a new K(Ca) 3.1 channel inhibitor prevents T-cell activation and inflammation in a rat model of inflammatory bowel disease. Br J Pharmacol (2013) 0.96
Langerhans cells and the cells of Langerhans cell histiocytosis do not express DC-SIGN. Blood (2001) 0.96
Detection of S-phase cells in tissue sections by in situ DNA replication. Nat Cell Biol (2000) 0.94
A minimally invasive immunocytochemical approach to early detection of oral squamous cell carcinoma and dysplasia. Br J Cancer (2006) 0.94
MCM immunocytochemistry as a first line cervical screening test in developing countries: a prospective cohort study in a regional cancer centre in India. Br J Cancer (2007) 0.93
Amplification of chromosome 5p correlates with increased expression of Skp2 in HPV-immortalized keratinocytes. Oncogene (2003) 0.93
Biologic factors and response to radiotherapy in carcinoma of the cervix. Int J Gynecol Cancer (2001) 0.93
The accuracy of antenatal ultrasound in the detection of facial clefts in a low-risk screening population. Ultrasound Obstet Gynecol (2001) 0.90
Development of T-leukaemias in CD45 tyrosine phosphatase-deficient mutant lck mice. EMBO J (2000) 0.89
Minichromosome maintenance (Mcm) proteins, cyclin B1 and D1, phosphohistone H3 and in situ DNA replication for functional analysis of vulval intraepithelial neoplasia. Br J Cancer (2003) 0.89
Malignant germ cell tumours of childhood: new associations of genomic imbalance. Br J Cancer (2007) 0.89
Lack of correlation between predicted and actual off-target effects of short-interfering RNAs targeting the human papillomavirus type 16 E7 oncogene. Br J Cancer (2013) 0.88
An increase in DNA double-strand breaks, induced by Ku70 depletion, is associated with human papillomavirus 16 episome loss and de novo viral integration events. J Pathol (2007) 0.87
DC-SIGN association with the Th2 environment of lepromatous lesions: cause or effect? J Pathol (2006) 0.87
Check ... checkmate. Countering the con games of drug abusers. Postgrad Med (1985) 0.87
FOXP3 immunohistochemistry on formalin-fixed paraffin-embedded tissue: poor correlation between different antibodies. J Clin Pathol (2008) 0.87
Altered expression of desmosomal components in high-grade squamous intraepithelial lesions of the cervix. Virchows Arch (2003) 0.86
Immunohistochemical estimation of cell cycle phase in laryngeal neoplasia. Br J Cancer (2006) 0.86
Genomic imbalances in 70 snap-frozen cervical squamous intraepithelial lesions: associations with lesion grade, state of the HPV16 E2 gene and clinical outcome. Br J Cancer (2004) 0.86
Mucopolysaccharidosis type VII associated with hydrops fetalis: histopathological and ultrastructural features with genetic implications. J Clin Pathol (1997) 0.84
Early genetic events in HPV immortalised keratinocytes. Genes Chromosomes Cancer (2001) 0.84
Biology of childhood germ cell tumours, focussing on the significance of microRNAs. Andrology (2014) 0.83
Expression of DC-SIGN in human foreskin may facilitate sexual transmission of HIV. J Clin Pathol (2004) 0.83
Head shop compound abuse amongst attendees of the Drug Treatment Centre Board. Ir Med J (2010) 0.83
Ewing's tumour: novel recurrent chromosomal abnormalities demonstrated by molecular cytogenetic analysis of seven cell lines and one primary culture. Cytogenet Genome Res (2002) 0.83
Cytomegalovirus infection of bile duct epithelial cells, hepatic artery and portal venous endothelium in relation to chronic rejection of liver grafts. J Hepatol (1999) 0.83
The host response to lesions induced by human papillomavirus. Ciba Found Symp (1994) 0.82
An eye mobile screening unit. Sight Sav Rev (1977) 0.82
The transcription factor E2F-1 in SV40 T antigen-induced cerebellar Purkinje cell degeneration. Mol Cell Neurosci (1998) 0.81
Molecular cytogenetic analysis consistently identifies translocations involving chromosomes 1, 2 and 15 in five embryonal rhabdomyosarcoma cell lines and a PAX-FOXO1A fusion gene negative alveolar rhabdomyosarcoma cell line. Cytogenet Cell Genet (2001) 0.81
Development of peptide aptamer microarrays for detection of HPV16 oncoproteins in cell extracts. Anal Biochem (2010) 0.81
Molecular cytogenetic analysis of cervical squamous cell carcinoma cells demonstrates discordant levels of numerical and structural chromosomal instability and identifies 'selected' chromosome rearrangements. Cytogenet Genome Res (2010) 0.81
Novel method for the production of multiple colour chromosome paints for use in karyotyping by fluorescence in situ hybridisation. Genes Chromosomes Cancer (1999) 0.80
Methylator phenotype of malignant germ cell tumours in children identifies strong candidates for chemotherapy resistance. Br J Cancer (2011) 0.80
Sexual dimorphism in the neonatal gonad. Acta Paediatr Suppl (1999) 0.80
Radiologically-guided cutting needle biopsy for suspected malignancy in childhood. Clin Radiol (1993) 0.80
Assessment of cell cycle state may facilitate the histopathological diagnosis of malignant mesothelioma. Histopathology (2003) 0.79
A paucity of liver disease in Canadian Inuit with chronic hepatitis B virus, subgenotype B6 infection. J Viral Hepat (2013) 0.79
The alloantibody response in the allogeneically pregnant rat. IV. Analysis of the alloantibody specificities with monoclonal antibodies. J Immunol (1986) 0.79
Diagnosis of bladder cancer by immunocytochemical detection of minichromosome maintenance protein-2 in cells retrieved from urine. Br J Cancer (2012) 0.79
Clinical trials with etanidazole (SR-2508) by the Radiation Therapy Oncology Group (RTOG). Radiother Oncol (1991) 0.78
Lipoprotein lipase is frequently overexpressed or translocated in cervical squamous cell carcinoma and promotes invasiveness through the non-catalytic C terminus. Br J Cancer (2012) 0.78
Somatic genetic changes in lung cancer and precancerous lesions. Ann Oncol (1995) 0.77
Different susceptibility of cervical keratinocytes containing human papillomavirus to cell-mediated cytotoxicity. Chin Med J (Engl) (1996) 0.77
"Natural" presentation of human papillomavirus type-16 E7 protein to immunocompetent mice results in antigen-specific sensitization or sustained unresponsiveness. Eur J Immunol (1994) 0.77
Increased expression of minichromosome maintenance protein 2 in active inflammatory bowel disease. Colorectal Dis (2004) 0.76
Packing products for customers: an ergonomics evaluation of three supermarket checkouts. Appl Ergon (1995) 0.76
Reproducibility and comparison of cardiac output measurement by transthoracic bioimpedance and thermodilution methods in critically ill patients. Clin Intensive Care (1993) 0.75
Dobutamine and terlipressin in patients with septic shock. Br J Anaesth (2008) 0.75
Introducing a specialist drug kardex can significantly change prescribing practices for VTE in cancer patients. Ir Med J (2014) 0.75
HCV and HIV binding lectin, DC-SIGNR, is expressed at all stages of HCV induced liver disease. J Clin Pathol (2004) 0.75
Primary or secondary malignancy? Fingerprint evidence. Clin Oncol (R Coll Radiol) (2003) 0.75
Regional metastasis in polymorphous low grade adenocarcinoma. Report of a case. Int J Oral Maxillofac Surg (1997) 0.75
Nursing the Net. Lamp (1996) 0.75
Use of an Ohmeda ear oximetry probe for "buccal" oximetry. Can J Anaesth (1990) 0.75
An inventory to measure medical staff knowledge of behavioral methods with pediatric pain patients. J Behav Ther Exp Psychiatry (1988) 0.75
Assessment, re-design and evaluation of changes to the driver's cab in a suburban electric train. Appl Ergon (2000) 0.75
Removal of carcinoma cells from contaminated bone marrow using the lipophilic cation rhodamine 123. Clin Cancer Res (1995) 0.75
Tissue reaction and loosening of carbon-reinforced polyethylene arthroplasties. J Bone Joint Surg Br (1992) 0.75
Management of high grade parotid carcinomas. Br J Surg (1989) 0.75
Dose escalation of the hypoxic cell sensitizer etanidazole combined with ifosfamide, carboplatin, etoposide, and autologous hematopoietic stem cell support. Clin Cancer Res (1998) 0.75
Abnormal (marker) chromosomes in two patients with acute myelofibrosis. Arch Intern Med (1969) 0.75